Rolf Ljung

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung et al. · New England Journal of Medicine · 2013 · 431 citations · Full text

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 319 citations

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

Jan Astermark, Pia Petrini, Lilian Tengborn et al. · British Journal of Haematology · 1999 · 279 citations · Full text

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Consensus Summary, Preventive Medicine, Secondary Prophylaxis +14

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Kathelijn Fischer, Katarina Steen Carlsson, Pia Petrini et al. · Blood · 2013 · 220 citations · Full text